| Document Date: 2010-09-10 14:17:13
Open Document File Size: 244,96 KBShare Result on Facebook
City Bradenton / Tokyo / SOMERSET / / Company Terumo Corporation / Terumo Interventional Systems Terumo Interventional Systems / IMMEDIATE RELEASE TERUMO MEDICAL CORPORATION / Bloomberg / Terumo Medical Corporation / Reuters / Tokyo Stock Exchange / Terumo Interventional Systems / / Continent Europe / / Country Japan / United States / / Currency USD / / / Facility Bradenton Cardiology Center / / IndustryTerm medical devices / entry-site management products / valued products / this innovative peripheral artery disease treatment / medical device manufacturers / healthcare professionals / embolization products / sterile connection devices / healthcare markets / healthcare market / hypodermic needle products / healthcare providers / / MarketIndex Nikkei 225 / / MedicalCondition innovative peripheral artery disease / tiredness / pain / peripheral artery disease / / MedicalTreatment cardiothoracic surgery / percutaneous transluminal angioplasty / embolization / catheter / catheters / amputation / / Organization U.S. Food & Drug Administration / SFA / American Heart Association / Bradenton Cardiology Center / / Person Takeuchi / Srinivas Iyengar / Ballard Smith / George Thomas / Joanna Murray / Robert J. Murphy / / / Position physician / Clinical Project Manager / President and CEO / Principal Investigator for the OSPREY trial / / ProvinceOrState New Jersey / Florida / / Technology ultrasound / / URL www.BradentonHeart.com / /
SocialTag |
Press Contact: Robert J. Murphy The Storch-Murphy Group